Publicaciones en las que colabora con Manuel de-Miguel (29)

2020

  1. Mitochondrial imbalance as a new approach to the study of fibromyalgia

    Open Access Rheumatology: Research and Reviews, Vol. 12, pp. 175-185

2017

  1. Amitriptyline down-regulates coenzyme Q10biosynthesis in lung cancer cells

    European Journal of Pharmacology, Vol. 797, pp. 75-82

2016

  1. Amitriptyline induces mitophagy that precedes apoptosis in human HepG2 cells

    Genes and Cancer, Vol. 7, Núm. 7-8, pp. 260-277

  2. Targeted multifunctional tannic acid nanoparticles

    RSC Advances, Vol. 6, Núm. 9, pp. 7279-7287

2014

  1. Clinical symptoms in fibromyalgia are associated to overweight and lipid profile

    Rheumatology International, Vol. 34, Núm. 3, pp. 419-422

  2. Coenzyme Q10 therapy

    Molecular Syndromology, Vol. 5, Núm. 3-4, pp. 187-197

  3. NLRP3 inflammasome is activated in fibromyalgia: The effect of coenzyme Q10

    Antioxidants and Redox Signaling, Vol. 20, Núm. 8, pp. 1169-1180

  4. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder

    Brain, Behavior, and Immunity, Vol. 36, pp. 111-117

2013

  1. Apoptotic microtubules delimit an active caspase free area in the cellular cortex during the execution phase of apoptosis

    Cell Death and Disease, Vol. 4, Núm. 3

  2. Can coenzyme Q10 improve clinical and molecular parameters in fibromyalgia?

    Antioxidants and Redox Signaling, Vol. 19, Núm. 12, pp. 1356-1361

  3. Is inflammation a mitochondrial dysfunction-dependent event in fibromyalgia?

    Antioxidants and Redox Signaling, Vol. 18, Núm. 7, pp. 800-807

2012

  1. Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient

    Nutrition, Vol. 28, Núm. 11-12, pp. 1200-1203

  2. Oral treatment with amitriptyline induces coenzyme Q deficiency and oxidative stress in psychiatric patients

    Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 341-345

  3. Oxidative stress correlates with headache symptoms in Fibromyalgia: Coenzyme Q 10 effect on clinical improvement

    PLoS ONE, Vol. 7, Núm. 4

  4. Recovery of MERRF Fibroblasts and Cybrids Pathophysiology by Coenzyme Q10

    Neurotherapeutics, Vol. 9, Núm. 2, pp. 446-463

  5. Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the disease

    British Journal of Pharmacology, Vol. 167, Núm. 6, pp. 1311-1328

2011

  1. Amitriptyline induces coenzyme Q deficiency and oxidative damage in mouse lung and liver

    Toxicology Letters, Vol. 204, Núm. 1, pp. 32-37

  2. Apoptotic microtubule network organization and maintenance depend on high cellular ATP levels and energized mitochondria

    Apoptosis, Vol. 16, Núm. 4, pp. 404-424

  3. Clinical symptoms in Fibromyalgia are better associated to lipid peroxidation levels in blood mononuclear cells rather than in plasma

    PLoS ONE, Vol. 6, Núm. 10

  4. Coenzyme Q10: A novel therapeutic approach for Fibromyalgia? Case series with 5 patients

    Mitochondrion, Vol. 11, Núm. 4, pp. 623-625